Joshua Daniel Brandstadter, MD, PhD, MSc

Brandstadter JD, Lurain K, Nasta SD, and Fajgenbaum DC Chapter 59: Castleman Disease and Rosai-Dorfman-Destombes Disease , Classical Hematology: 2026,601

Laczko D, Pillai V, Frank D, Brandstadter JD, Fajgenbaum DC How I diagnose Castleman disease , American Journal of Clinical Pathology, 165(3): 2026,aqaf147

Shyamsundar S, Sarmiento Bustamante M, Borys L, Lim MS, Bagg A, Lechowicz MJ, Alapat D, Chadburn A, Srkalovic G, van Rhee F, Austin B, Brandstadter JD, Fajgenbaum DC Breast-implant associated unicentric castleman disease: a case report , Current Problems in Cancer Case Reports, 21: 2026,100404

Kurz L, Lutge M, De Martin A, Cheng H-W, Bugar E, Stanossek Y, Meili S, Brandstadter JD, Maillard I, Onder L, Ludewig B A common progenitor gives rise to fibroblastic reticular cells and vascular smooth muscle cells in murine lymph nodes , Journal of Experimental Medicine, 2(223): 2026,e20242300

McHugh K, Huang Y, Austin B, Borys L, Irvine A, Alapat D, Bagg A, Chadburn A, Lechowicz MJ, Lim M, Srkalovic G, van Rhee F, Fajgenbaum D, Zhang L, Brandstadter J Idiopathic multicentric castleman disease unresponsive to one IL-6 inhibitor may respond to another IL-6 inhibitor , American Society of Hematology Annual Meeting, Orlando, FL: 2025

Steven Rowe, Mariam Goubran, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Bridget Austin, Kathleen McNicholas, Marley Blommers, Junyan Shi, Lisa K Peterson, Lusia Sepiashvili, Andre Mattman, Joshua D Brandstadter, David C Fajgenbaum, Luke Y C Chen Ferritin, C-Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLH , Am J Hematol: 2025

Mechthild Lütge, Lisa Kurz, Yves Stanossek, Samuel Meili, Hung-Wei Cheng, Angelina De Martin, Joshua Brandstadter, Ivan Maillard, Mark D Robinson, Sandro J Stoeckli, Natalia B Pikor, Lucas Onder, Burkhard Ludewig Fibroblastic reticular cells form reactive myeloid cell niches in human lymph nodes , Science Immunology, 10(107): 2025,eads6820

Dave Maurice De Sousa, Eric Perkey, Laure Le Corre, Salix Boulet, Daniela Gómez Atria, Anneka Allman, Frédéric Duval, Jean-François Daudelin, Joshua D Brandstadter, Katlyn Lederer, Sarah Mezrag, Livia Odagiu, Myriam Ennajimi, Marion Sarrias, Hélène Decaluwe, Ute Koch, Freddy Radtke, Burkhard Ludewig, Christian W Siebel, Ivan Maillard, Nathalie Labrecque Early Notch signals from fibroblastic reticular cells program effector CD8+ T cell differentiation , J Exp Med, 5(222): 2025,e20231758

Sheila K Pierson, Joshua D Brandstadter, Drew Torigian, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat MD, Corey Casper, Amy Chadburn, Shanmuganathan Chandrakasan, Angela Dispenzieri, Alexander Fosså, Christian Hoffmann, Makoto Ide, Razelle Kurzrock, Sudipto Mukherjee, Sunita D Nasta, José-Tomás Navarro, Ariela Noy, Eric Oksenhendler, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Matthew J Streetly, Raymond Siu Ming Wong, Lu Zhang, Megan S Lim, Gordan Srkalovic, Frits van Rhee, David C Fajgenbaum Characterizing the heterogeneity of Castleman disease and oligocentric subtype: Findings from the ACCELERATE registry , Blood Advances: 2025

Anneka Allman, Brian T Gaudette, Samantha Kelly, Nagham Alouche, Léolène J Carrington, Eric Perkey, Joshua D Brandstadter, Riley Outen, Ashley Vanderbeck, Katlyn Lederer, Yeqiao Zhou, Robert B Faryabi, Tanner F Robertson, Janis K Burkhardt, Anastasia Tikhonova, Iannis Aifantis, Leonardo Scarpellino, Ute Koch, Freddy Radtke, Mechthild Lütge, Angelina De Martin, Burkhard Ludewig, Lena Tveriakhina, Achim Gossler, Lluc Mosteiro, Christian W Siebel, Daniela Gómez Atria, Sanjiv A Luther, David Allman, Ivan Maillard Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs , Immunity, 58(1): 2025